Turn Therapeutics (TTRX) Total Current Liabilities (2024 - 2026)

Turn Therapeutics' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities changed N/A year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.0 million, up 748.02% from the prior year.
• Total Current Liabilities eased to $5.1 million in Q1 2026 per TTRX's latest filing, from $6.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $6.0 million in Q4 2025 and bottomed at $707932.0 in Q4 2024.
• The 3-year median for Total Current Liabilities is $3.7 million (2025), against an average of $3.5 million.
• Biggest YoY gain for Total Current Liabilities was 748.02% in 2025; the steepest drop was 748.02% in 2025.
• Year by year, Total Current Liabilities stood at $707932.0 in 2024, then surged by 748.02% to $6.0 million in 2025, then retreated by 14.54% to $5.1 million in 2026.
• Per Business Quant, the three latest TTRX Total Current Liabilities figures stand at $5.1 million (Q1 2026), $6.0 million (Q4 2025), and $2.3 million (Q3 2025).